- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03917810
Acute Responses to Manipulating Dietary Carbohydrate Content on Free-living Physical Activity Energy Expenditure
Dietary sugar and carbohydrate intakes will be manipulated for 3 days in a randomised crossover design. All food will be provided. Free-living physical activity energy expenditure will be measured using combined heart rate and accelerometry. Metabolic and appetite/mood responses to 3 days on each diet will be measured.
Each participant will undergo 3 days of each diet:
- Moderate sugar - reflecting the composition of a typical European diet
- Low sugar - similar macronutrient composition of a typical European diet but with <5% energy intake from free sugars (as per government guidelines)
- Low carbohydrate - low carbohydrate diet with <5% energy intake from sugar and <8% energy intake from carbohydrate, replacing carbohydrate energy with fat
Studienübersicht
Detaillierte Beschreibung
Guidelines calling for dietary free sugars to be reduced have been formulated from evidence that diets high in sugar are associated with high energy intake. In theory, by reducing the intake of sugars, calorie surplus will be reduced and energy balance will be maintained. However, when referring to interventions/behaviours that influence energy balance, both sides of the energy balance equation need to be considered. Alterations in nutrients may influence aspects of energy expenditure, not solely energy intake, and this may have implications for the efficacy of guidelines seeking to influence energy intake.
It is important to consider energy expenditure in the context of health. The most variable component of energy expenditure between individuals is physical activity energy expenditure (PAEE), which varies from ~600-2100 kcal per day in men of a similar demographic. Current guidelines do not regard the effect that changing dietary sugar might have on PAEE and therefore total energy expenditure.
Furthermore, there is increasing interest in restricting overall carbohydrate intake to treat metabolic disease or achieve ketogenesis. Very little is known about nutrition-physical activity interactions with this type of intervention.
This study will prescribe 3 diets to healthy males for 3 days in a randomised crossover design, where each participant will consume each of the diets. All food will be prepared and provided by the study team. The diets are as follows:
- Moderate sugar - reflecting the composition of a typical European diet
- Low sugar - similar macronutrient composition of a typical European diet but with <5% energy intake from free sugars (as per government guidelines)
- Low carbohydrate - low carbohydrate diet with <5% energy intake from sugar and <8% energy intake from carbohydrate, replacing carbohydrate energy with fat
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Somerset
-
Bath, Somerset, Vereinigtes Königreich, BA2 7AY
- University of Bath
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Body mass index 18.5-29.9 kg∙m-2
- Age 18-65 years
- Male
- Able and willing to provide informed consent and safely comply with study procedures
- No anticipated changes in physical activity during the study (e.g. holidays)
Exclusion Criteria:
- Any reported condition or behaviour deemed either to pose undue personal risk to the participant or introduce bias
- Any diagnosed metabolic disease (e.g. type 1 or type 2 diabetes)•Any reported use of substances which may pose undue personal risk to the participants or introduce bias into the experiment
- Lifestyle not conforming to standard sleep-wake cycle (e.g. shift worker)
- Any reported recent (<6 months) change in body mass (±3%)
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: MODSUG
Diet consisting of 50% carbohydrate (20% sugar), 15% protein, 35% fat
|
Die Zusammensetzung der Makronährstoffe (insbesondere Art und/oder Menge der Kohlenhydrate) wird manipuliert
|
|
Experimental: LOWSUG
Diet consisting of 50% carbohydrate (<5% sugar), 15% protein, 35% fat
|
Die Zusammensetzung der Makronährstoffe (insbesondere Art und/oder Menge der Kohlenhydrate) wird manipuliert
|
|
Experimental: LOWCHO
Diet consisting of <8% carbohydrate (<5% sugar), 15% protein, >77% fat
|
Die Zusammensetzung der Makronährstoffe (insbesondere Art und/oder Menge der Kohlenhydrate) wird manipuliert
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Physical activity energy expenditure (kj/day or kcal/day)
Zeitfenster: 3 days
|
Physical activity energy expenditure measured using individually-calibrated combined heart rate and accelerometry (kj/day or kcal/day)
|
3 days
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Time spent in different physical activity intensities (MET categories) (minutes)
Zeitfenster: 3 days
|
Time spent in different physical activity intensities (MET categories) (minutes) using individually-calibrated combined heart rate and accelerometry
|
3 days
|
|
Energy expended in different physical activity intensities (MET categories) (kJ/day or kcal/day)
Zeitfenster: 3 days
|
Energy expended in different physical activity intensities (MET categories) (kJ/day or kcal/day) using individually-calibrated combined heart rate and accelerometry
|
3 days
|
|
Energy expended in the postprandial period (kJ or kcal)
Zeitfenster: 3 days
|
Energy expended in the postprandial period (kJ or kcal) measured using individually-calibrated combined heart rate and accelerometry
|
3 days
|
|
Fasting blood glucose concentrations
Zeitfenster: 3 days
|
Measures of blood glucose concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood insulin concentrations
Zeitfenster: 3 days
|
Measures of blood insulin concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood triglyceride concentrations
Zeitfenster: 3 days
|
Measures of blood triglyceride concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood non-esterified fatty acid concentrations
Zeitfenster: 3 days
|
Measures of blood non-esterified fatty acid concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood lactate concentrations
Zeitfenster: 3 days
|
Measures of blood lactate concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood beta-hydroxybutyrate concentrations
Zeitfenster: 3 days
|
Measures of blood beta-hydroxybutyrate concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood leptin concentrations
Zeitfenster: 3 days
|
Measures of blood leptin concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood fibroblast growth factor-21 concentrations
Zeitfenster: 3 days
|
Measures of blood fibroblast growth factor-21 concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood total cholesterol concentrations
Zeitfenster: 3 days
|
Measures of blood total cholesterol concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood high density lipoprotein concentrations
Zeitfenster: 3 days
|
Measures of blood high density lipoprotein concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood low density lipoprotein concentrations
Zeitfenster: 3 days
|
Measures of blood low density lipoprotein concentrations pre- and post-intervention.
|
3 days
|
|
Food preference ratings
Zeitfenster: 3 days
|
Food preference ratings determined by computer task measured pre- and post-intervention
|
3 days
|
|
Subjective appetite and mood ratings
Zeitfenster: 3 days
|
Measured by 0-100 mm visual analogue scales measured pre- and post-intervention
|
3 days
|
|
Blood pressure
Zeitfenster: 3 days
|
Blood pressure using an automated sphygmomanometer pre- and post-intervention
|
3 days
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Betts JA, Richardson JD, Chowdhury EA, Holman GD, Tsintzas K, Thompson D. The causal role of breakfast in energy balance and health: a randomized controlled trial in lean adults. Am J Clin Nutr. 2014 Aug;100(2):539-47. doi: 10.3945/ajcn.114.083402. Epub 2014 Jun 4.
- Smith HA, Gonzalez JT, Thompson D, Betts JA. Dietary carbohydrates, components of energy balance, and associated health outcomes. Nutr Rev. 2017 Oct 1;75(10):783-797. doi: 10.1093/nutrit/nux045.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- EP 17/18 219
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .